Back to CVE records
Medium 5.5HealthcarePublished Mar 31, 2021

CVE-2021-28657Infinite loop in Apache Tika's MP3 parser

Updated under an hour ago ()

Does this affect you?

It affects Apache Software Foundation Apache Tika and 5 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 2.74%, higher than 86% of scored CVEs.

A carefully crafted or corrupt file may trigger an infinite loop in Tika's MP3Parser up to and including Tika 1.25. Apache Tika users should upgrade to 1.26 or later.

CVSS
5.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
Weakness (CWE)
CWE-835
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
2.74% (percentile 86)
Assigned by
apache
NVD analysis
Modified
Record last updated
Feb 13, 2025
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Apache Software Foundation Apache Tika
apache_software_foundation:apache_tika (from the name)
from Apache Tika before 1.26
CNA record
apache tika
apache:tika
through 1.25
NVD
oracle healthcare_foundation
oracle:healthcare_foundation
7.3.0; 8.0.0; 8.1.0
NVD
oracle primavera_unifier
oracle:primavera_unifier
from 17.7 through 17.12; 18.8; 19.12; 20.12
NVD
oracle webcenter_portal
oracle:webcenter_portal
12.2.1.3.0; 12.2.1.4.0
NVD
oracle communications_messaging_server
oracle:communications_messaging_server
8.1
NVD

References

  • x-refsource-misc, mailing-list, vendor-advisory
  • mailing-list, x-refsource-mlist
  • x-refsource-misc, patch, third-party-advisory
  • x-refsource-confirm, third-party-advisory
  • x-refsource-misc, patch, third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.